申请人:Janssen Pharmaceutica NV
公开号:US20150376193A1
公开(公告)日:2015-12-31
Disclosed is a process for the preparation of the following compounds:
where R
1
, R
1a
and R
2a
have the definitions in the description, as well as a process to prepare other intermediates that may be useful to synthesise downstream products, especially compounds that are useful as medicaments, for instance Bruton's tyrosine kinase (Btk) inhibitors such as ibrutinib. Also disclosed are other processes, other intermediates and compounds per se.
本发明公开了以下化合物的制备方法:其中R1、R1a和R2a的定义如说明书中所述,并且公开了制备其他中间体的方法,这些中间体可能有助于合成下游产品,特别是作为药物有用的化合物,例如布鲁顿酪氨酸激酶(Btk)抑制剂,如伊布替尼。此外,还公开了其他方法,其他中间体和化合物本身。